Cargando…

The Evolving Role of CD8(+)CD28(−) Immunosenescent T Cells in Cancer Immunology

Functional, tumor-specific CD8(+) cytotoxic T lymphocytes drive the adaptive immune response to cancer. Thus, induction of their activity is the ultimate aim of all immunotherapies. Success of anti-tumor immunotherapy is precluded by marked immunosuppression in the tumor microenvironment (TME) leadi...

Descripción completa

Detalles Bibliográficos
Autores principales: Huff, Wei X., Kwon, Jae Hyun, Henriquez, Mario, Fetcko, Kaleigh, Dey, Mahua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6600236/
https://www.ncbi.nlm.nih.gov/pubmed/31181772
http://dx.doi.org/10.3390/ijms20112810
_version_ 1783431071338070016
author Huff, Wei X.
Kwon, Jae Hyun
Henriquez, Mario
Fetcko, Kaleigh
Dey, Mahua
author_facet Huff, Wei X.
Kwon, Jae Hyun
Henriquez, Mario
Fetcko, Kaleigh
Dey, Mahua
author_sort Huff, Wei X.
collection PubMed
description Functional, tumor-specific CD8(+) cytotoxic T lymphocytes drive the adaptive immune response to cancer. Thus, induction of their activity is the ultimate aim of all immunotherapies. Success of anti-tumor immunotherapy is precluded by marked immunosuppression in the tumor microenvironment (TME) leading to CD8(+) effector T cell dysfunction. Among the many facets of CD8(+) T cell dysfunction that have been recognized—tolerance, anergy, exhaustion, and senescence—CD8(+) T cell senescence is incompletely understood. Naïve CD8(+) T cells require three essential signals for activation, differentiation, and survival through T-cell receptor, costimulatory receptors, and cytokine receptors. Downregulation of costimulatory molecule CD28 is a hallmark of senescent T cells and increased CD8(+)CD28(−) senescent populations with heterogeneous roles have been observed in multiple solid and hematogenous tumors. T cell senescence can be induced by several factors including aging, telomere damage, tumor-associated stress, and regulatory T (Treg) cells. Tumor-induced T cell senescence is yet another mechanism that enables tumor cell resistance to immunotherapy. In this paper, we provide a comprehensive overview of CD8(+)CD28(−) senescent T cell population, their origin, their function in immunology and pathologic conditions, including TME and their implication for immunotherapy. Further characterization and investigation into this subset of CD8(+) T cells could improve the efficacy of future anti-tumor immunotherapy.
format Online
Article
Text
id pubmed-6600236
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-66002362019-07-16 The Evolving Role of CD8(+)CD28(−) Immunosenescent T Cells in Cancer Immunology Huff, Wei X. Kwon, Jae Hyun Henriquez, Mario Fetcko, Kaleigh Dey, Mahua Int J Mol Sci Review Functional, tumor-specific CD8(+) cytotoxic T lymphocytes drive the adaptive immune response to cancer. Thus, induction of their activity is the ultimate aim of all immunotherapies. Success of anti-tumor immunotherapy is precluded by marked immunosuppression in the tumor microenvironment (TME) leading to CD8(+) effector T cell dysfunction. Among the many facets of CD8(+) T cell dysfunction that have been recognized—tolerance, anergy, exhaustion, and senescence—CD8(+) T cell senescence is incompletely understood. Naïve CD8(+) T cells require three essential signals for activation, differentiation, and survival through T-cell receptor, costimulatory receptors, and cytokine receptors. Downregulation of costimulatory molecule CD28 is a hallmark of senescent T cells and increased CD8(+)CD28(−) senescent populations with heterogeneous roles have been observed in multiple solid and hematogenous tumors. T cell senescence can be induced by several factors including aging, telomere damage, tumor-associated stress, and regulatory T (Treg) cells. Tumor-induced T cell senescence is yet another mechanism that enables tumor cell resistance to immunotherapy. In this paper, we provide a comprehensive overview of CD8(+)CD28(−) senescent T cell population, their origin, their function in immunology and pathologic conditions, including TME and their implication for immunotherapy. Further characterization and investigation into this subset of CD8(+) T cells could improve the efficacy of future anti-tumor immunotherapy. MDPI 2019-06-08 /pmc/articles/PMC6600236/ /pubmed/31181772 http://dx.doi.org/10.3390/ijms20112810 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Huff, Wei X.
Kwon, Jae Hyun
Henriquez, Mario
Fetcko, Kaleigh
Dey, Mahua
The Evolving Role of CD8(+)CD28(−) Immunosenescent T Cells in Cancer Immunology
title The Evolving Role of CD8(+)CD28(−) Immunosenescent T Cells in Cancer Immunology
title_full The Evolving Role of CD8(+)CD28(−) Immunosenescent T Cells in Cancer Immunology
title_fullStr The Evolving Role of CD8(+)CD28(−) Immunosenescent T Cells in Cancer Immunology
title_full_unstemmed The Evolving Role of CD8(+)CD28(−) Immunosenescent T Cells in Cancer Immunology
title_short The Evolving Role of CD8(+)CD28(−) Immunosenescent T Cells in Cancer Immunology
title_sort evolving role of cd8(+)cd28(−) immunosenescent t cells in cancer immunology
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6600236/
https://www.ncbi.nlm.nih.gov/pubmed/31181772
http://dx.doi.org/10.3390/ijms20112810
work_keys_str_mv AT huffweix theevolvingroleofcd8cd28immunosenescenttcellsincancerimmunology
AT kwonjaehyun theevolvingroleofcd8cd28immunosenescenttcellsincancerimmunology
AT henriquezmario theevolvingroleofcd8cd28immunosenescenttcellsincancerimmunology
AT fetckokaleigh theevolvingroleofcd8cd28immunosenescenttcellsincancerimmunology
AT deymahua theevolvingroleofcd8cd28immunosenescenttcellsincancerimmunology
AT huffweix evolvingroleofcd8cd28immunosenescenttcellsincancerimmunology
AT kwonjaehyun evolvingroleofcd8cd28immunosenescenttcellsincancerimmunology
AT henriquezmario evolvingroleofcd8cd28immunosenescenttcellsincancerimmunology
AT fetckokaleigh evolvingroleofcd8cd28immunosenescenttcellsincancerimmunology
AT deymahua evolvingroleofcd8cd28immunosenescenttcellsincancerimmunology